The role of miR-150 in normal and malignant hematopoiesis.
about
The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapyEctopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cellsCirculating microRNA-122 as Potential Biomarker for Detection of Testosterone AbuseOpposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiaRole of microRNA-150 in solid tumors.Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth.Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growthMicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathwaysmiR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway.MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4.Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.Serum microRNAs as Biomarkers of Human Lymphocyte Activation in Health and Disease.Impaired vascular function contributes to exercise intolerance in chronic kidney disease.miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation.MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatmentSerum microRNA-150 predicts prognosis for early-stage non-small cell lung cancer and promotes tumor cell proliferation by targeting tumor suppressor gene SRCIN1.ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.c-Met inhibition in a HOXA9/Meis1 model of CN-AML.Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignanciesmiR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3Toward the human cellular microRNAome.Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression.Evidence that circulating proteins are more promising than miRNAs for identification of patients with squamous cell carcinoma of the tongue.MicroRNA-150 targets ELK1 and modulates the apoptosis induced by ox-LDL in endothelial cells.MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma.Integrated microRNA and mRNA network analysis of the human myometrial transcriptome in the transition from quiescence to labor.Changes in high-density lipoprotein-carried miRNA contribution to the plasmatic pool after consumption of dietary trans fat in healthy men.Circulating microRNA as Biomarkers in Hematological Malignancies.Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4.MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2.
P2860
Q26778301-8DB2E909-3D65-4E12-A6A2-A4C6F29D83F7Q28542491-921CC42A-AC71-4F5F-8DCB-1DD8785FA298Q28552000-10F68F68-8BFA-4489-9FCE-EC165B722A9BQ35707206-867A7215-141D-4244-BDF2-793A16D41859Q35803040-6B75A0EB-4832-4B07-862C-BE9E9FA92766Q35990849-541BDC98-21C7-4AEB-95A7-436307E23E32Q36106068-126072A1-260F-4D16-9386-87CEE8FDB95AQ36998316-C649421E-CA56-493A-99A6-019B28EDC968Q37330835-05102C09-2EDA-4598-9C0F-E2BC9443E205Q37421084-973C42F2-F6AB-40DC-A5B3-A1AE9541250BQ37504774-7FE5883C-6CF7-40FA-872F-EC1FD59D3C96Q38190915-ACDA37B1-29C3-47FF-AAB6-783D2634AA67Q38191609-B58EA363-5E81-45AE-9978-0156072C1B5BQ38829920-0C6603DE-AD21-4BCB-8FCE-DCA387D9DF62Q38873436-C3B9BB09-E3A7-4147-B648-F1166690FF6AQ39570483-4DE0181A-E338-4FE7-8554-F2BB63C94A53Q40048290-B8039188-BF30-46D0-A2EA-85793DADC199Q40279244-F51E1C70-152D-4303-BC1C-62CE3A88E5C6Q41044723-E1E66349-44BD-4EBC-9FCD-B4938434B442Q42251074-108BE046-CA8E-4FCE-9CEB-941868CEC692Q42421291-EB050C6E-FE57-4D2B-8A35-65DD7E015940Q42700737-14334565-A832-451F-8C1D-84CBCE93E732Q42777583-9FCA5D53-5295-45D3-A885-8CA678BE8213Q46371383-6C3D5F73-FD76-41D8-82BB-AEFA72A923BBQ47139209-5652A64D-2F78-4377-8E8D-4795153E4BB3Q48326851-1F677D03-017A-4ABA-A1AB-049A00557CC6Q49547726-53E9CA9F-787B-46C3-8AD9-2C689A3E65FFQ49978328-20941A10-1E82-422B-839A-BB8ED2DA7CE5Q50674958-6CD5E41F-1133-44E5-B9EA-BBD4F11832A7Q52900367-1E4763BD-E670-42B6-B2C5-A0DBE45EEC42Q53561107-8805EEA7-9934-4018-94F1-1E2F133789A2Q55119430-09BEE1E1-E41B-4927-B517-729528F62182Q55344920-3FDF13A1-9A36-48F7-B676-AD919122832C
P2860
The role of miR-150 in normal and malignant hematopoiesis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of miR-150 in normal and malignant hematopoiesis.
@en
type
label
The role of miR-150 in normal and malignant hematopoiesis.
@en
prefLabel
The role of miR-150 in normal and malignant hematopoiesis.
@en
P2093
P2860
P356
P1433
P1476
The role of miR-150 in normal and malignant hematopoiesis.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.346
P407
P577
2013-08-19T00:00:00Z
P5875
P6179
1012311187